Atlas Trials

A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers.

Clinical trial NCT01920854 · COMPLETED

Trial details

NCT number
NCT01920854
Sponsor
Rockwell Medical Technologies, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Kidney Failure, Chronic Therapy; Hemodialysis
Start date
2013-06-01
Primary completion
2013-09-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.